Mankind Pharma informs about board meeting

18 Jul 2023 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that a meeting of Board of Directors of the Company will be held on Wednesday, 2nd August 2023, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on 30th June 2023. Further, in continuation of its earlier letter dated 29th June 2023 under subject ‘Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's 'Code of Conduct for Prevention of Insider Trading', the trading window for trading in the securities of the Company shall remain closed upto 48 hours after the declaration of unaudited standalone and consolidated financial results of the Company for the quarter ended on 30th June 2023. The above notice and details are also being uploaded on the website of the Company at www.mankindpharma.com.

The above information is a part of company’s filings submitted to BSE.


Mankind Pharma Share Price

2126.85 -29.45 (-1.37%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.